Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Akebia Therapeutics (AKBA) over the last 3 years, with Q3 2025 value amounting to 0.22%.

  • Akebia Therapeutics' Return on Invested Capital changed N/A to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year change of. This contributed to the annual value of 0.53% for FY2019, which is 1500.0% down from last year.
  • Akebia Therapeutics' Return on Invested Capital amounted to 0.22% in Q3 2025.
  • Akebia Therapeutics' 5-year Return on Invested Capital high stood at 0.22% for Q3 2025, and its period low was 0.22% during Q3 2025.